H.R. 3, the drug pricing bill, is not the path forward.
Brett Guthrie: “H.R. 3, the drug pricing bill, is not the path forward.”
Editor's note · Context
Guthrie argues against H.R. 3, claiming it jeopardizes innovation for neurodegenerative disease treatments.
Share
More from Brett Guthrie
It is difficult for small businesses to stay in business. I would say if this equipment was going to do for small businesses what the Department of Energy and the other side is saying, they would buy them. They wouldn't have to be told to…
I absolutely would love to come back out to the bay area because it is beautiful, as well. In this bill, we are talking about electricity prices. China is building the electric car industry, but they are also building the power generation…
Mr. Speaker, I remind the gentlewoman that we did have a bill yesterday that passed. It hardly got any Democratic support. If you look at the enhanced tax credits that they set to expire to pay for the Green New Deal, so the moral cause…
Mr. Speaker, this is not the answer to the problem. This problem is not going to be solved by only putting people in jail and throwing away the key. I will tell you there are people who are purveyors of this illicit fentanyl that deserve…





